TP53 and neoplasm: Recent research indicates that mutant p53 can be transferred from tumor cells to fibroblasts via vesicles, activating their CAF characteristics and upregulating the secretion of proteins such as CCL2, CXCL1, G-CSF, GM-CSF, IL-1β, and IL-6 [67].